Mauro Bavetta

9PUBLICATIONS
22CO-AUTHORS
Clinical pharmacology and therapeuticsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Traditional Chinese medicine and treatmentsPharmaceutical delivery technologies
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Apr 06, 2022
Risankizumab for the treatment of moderate-to-severe psoriasis: A multicenter, retrospective, 1 year real-life study.

Giacomo Caldarola, Arianna Zangrilli, Nicoletta Bernardini

|Feb 03, 2021
The Effects of Association of Topical Polydatin Improves the Preemptive Systemic Treatment on EGFR Inhibitors Cutaneous Adverse Reactions.

Mauro Bavetta, Dionisio Silvaggio, Elena Campione

|Oct 06, 2020
Risankizumab: How to choose the right dose in clinical practice?

Chiara Pensa, Arianna Piccolo, Arianna Zangrilli

|Jun 20, 2020
Ixekizumab: One drug for an enigmatic psoriasis.

Arianna Piccolo, Chiara Pensa, Arianna Zangrilli

Pageof 2